Developer docs
API playgroundTry for free, no card

Search company profiles

Laurus Bio

Full company profile

uuid0002a8w

Namestring
Laurus Bio
Legal namestring
Laurus Bio Private Limited
Websiteurl
laurus.bio
Company typeenum
Private
Founded yearint
2005
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBangalore, India
HQ citystring
Bangalore
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
recombinant proteins, precision fermentation, cell culture media, CDMO services, growth factors
Industry1 code
PRIMARYAFANAKAF
Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Recombinant Proteins & Biomanufacturing
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Recombinant Protein and Growth Factor Product Sales
TypeOne Time License
Description

Sale of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements including Rc Trypsin, Rc Human Albumin, Rc Transferrin, Rc FGFb, Rc EGF-L, Rc IGF1-LR3, Rc Thermolysin, and Rc Carboxypeptidase B. Products are available in liquid and powder forms for biopharma, cell culture, and food applications.

laurus.bio
2CDMO (Contract Development and Manufacturing Organization) Services
TypeProfessional Services
Description

Fee-for-service precision fermentation expertise offered as a CDMO to biomanufacturers. Services span clone development, strain engineering, bioprocess and analytical test development, fermentation scale-up, and large-scale commercial manufacturing.

laurus.bio
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Laurus Bio manufactures animal-origin-free (AOF) recombinant proteins, growth factors, and cell culture media supplements using precision fermentation technology. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from clone development and process optimization through commercial-scale cGMP-compliant biomanufacturing.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 20 billion doses of medicines made safe with animal-free products
+2 more records
Product overview1 text field

Laurus Bio is an integrated research-driven biomanufacturing organization offering a portfolio of 100% animal-origin-free (AOF) recombinant proteins and growth factors manufactured through precision fermentation technology. The core product portfolio consists of Rc Trypsin (standard and USP grade), Rc Human Albumin (10% and 20%), Rc Transferrin, Rc Carboxypeptidase B, Rc Thermolysin, Rc FGFb, Rc EGF-L, and Rc IGF1-LR3. These products serve diverse applications including cultured meat, cell culture media, biologics and insulin manufacturing, vaccines, and stem cell culture and regenerative medicine. The company also provides CDMO (Contract Development and Manufacturing Organization) services for precision fermentation, encompassing clone development, strain engineering, bioprocess development, and scale-up capabilities ranging from R&D bench-scale to commercial-scale production (up to 45,000L fermenters). Additionally, Laurus Bio offers customized cell culture media formulations and bio-analytics services. All products are manufactured using expression systems including Escherichia Coli, Pichia Pastoris, and Hansenula polymorpha.

Product and service11 records
1Rc Carboxypeptidase B
CategoryRecombinant Enzymes
2Rc Human Albumin 20%
3Rc USP Trypsin
4Rc Trypsin (Standard)
5Rc Transferrin
6Rc Thermolysin
7Rc Human Albumin 10%
8Rc FGFb (basic Fibroblast Growth Factor)
9Rc EGF-L (Epidermal Growth Factor - Long)
10Rc IGF1-LR3
11CDMO Services
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOthers
Description

Laurus Bio is a wholly-owned subsidiary of Laurus Labs, a listed pharmaceutical company. Laurus Labs provides corporate governance, strategic direction, and operational support. Laurus Bio's corporate goals are aligned with those of Laurus Labs. The subsidiary model allows Laurus Bio to leverage Laurus Labs' pharmaceutical industry expertise and resources.

2National Biomedical Resources Indigenization Consortium (NBRIC)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Laurus Bio (formerly Richcore Life Sciences) is a member of NBRIC, a consortium focused on indigenous development of biomedical resources in India. Through this membership, Laurus Bio participates in national initiatives to build self-sufficiency in biotech manufacturing, including the expansion of recombinant protein manufacturing capabilities.

laurus.bio
Strategic tierMinorTypeOthers
Description

Laurus Bio (formerly Richcore Life Sciences) was recognized as an Unreasonable Company by the Unreasonable Group, a community of entrepreneurs addressing global challenges. This recognition highlights the company's mission to create safer, more reliable, and more sustainable solutions to tackle current health problems through animal-origin-free biomanufacturing.

Recent move8 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Animal-free recombinant protein company producing proteins via precision fermentation for food, beauty, and nutrition markets. Direct competitor in animal-origin-free recombinant protein space serving similar end markets.

TypeDirect peer
Description

Precision fermentation CDMO offering end-to-end microbial manufacturing services from strain engineering to commercial production. Directly comparable to Laurus Bio's CDMO offering for novel proteins and bio-based products.

TypeBroad incumbent
Description

Major supplier of recombinant proteins and cell culture reagents (R&D Systems brand) for biopharma and academic customers. Direct competitor in recombinant growth factors and cell culture media supplements.

TypeBroad incumbent
Description

Global food ingredient and agricultural processor with growing fermentation and alternative protein capabilities. Competes in the alternative protein space with fermentation-based ingredients, similar to Laurus Bio's cultivated meat serving strategy.

TypeBroad incumbent
Description

Engineered enzyme and protein manufacturer using directed evolution and protein engineering. Operates in pharmaceutical, food, and industrial markets with overlapping recombinant protein capabilities.

TypeEmerging player
Description

Synthetic biology platform company providing cell engineering and fermentation services to customers across food, pharma, and industrial biotechnology. Comparable CDMO-like service offerings for novel protein customers.

TypeBroad incumbent
Description

Major ingredient and biopharma supplier with fermentation-based manufacturing capabilities across nutrition, health, and personal care. Serves similar end markets to Laurus Bio but at much larger scale with diversified portfolio.

8Culture Biosciences
TypeDirect peer
Description

Microbial fermentation CDMO with bioreactor scale-up capabilities and bioprocess development services. Operates a similar business model to Laurus Bio's CDMO services for synthetic biology and fermentation-based manufacturers.

TypeDirect peer
Description

Animal-free dairy protein producer using precision fermentation, competing in the same AOF recombinant protein market as Laurus Bio. Both companies serve food industry customers seeking sustainable alternatives to animal-derived ingredients.

TypeBroad incumbent
Description

Large global enzyme and microbial fermentation company (formerly Novozymes) with extensive CDMO capabilities and precision fermentation infrastructure. Operates across food, beverage, and biopharma with broader portfolio than Laurus Bio.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Laurus Bio

Recombinant Proteins & Biomanufacturinglaurus.bio

Laurus Bio firmographics

Firmographics
Name
Laurus Bio
Legal name
Laurus Bio Private Limited
Website
https://laurus.bio
Company type
Private
Founded year
2005
Operating status
Operating
Headcount range
501–1,000 employees
Ownership category
akta.pro rank

Laurus Bio industry classification

Industry
Product category
Recombinant Proteins & Biomanufacturing
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYAFANAKAF
Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO)
Agriculture & Food Production/Meat, Poultry & Seafood Processing/Meat Alternatives (Plant-Based and Cultivated)

Keywords

  • Recombinant proteins
  • Precision fermentation
  • Cell culture media
  • CDMO services
  • Growth factors

Where Laurus Bio is headquartered

Location

Headquarters

HQ city
Bangalore
HQ country
India
HQ region
Asia

Offices4 records

Markets served

Laurus Bio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Supply Chain

Revenue model

  1. Recombinant Protein and Growth Factor Product Sales: Sale of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements including Rc Trypsin, Rc Human Albumin, Rc Transferrin, Rc FGFb, Rc EGF-L, Rc IGF1-LR3, Rc Thermolysin, and Rc Carboxypeptidase B. Products are available in liquid and powder forms for biopharma, cell culture, and food applications.
  2. CDMO (Contract Development and Manufacturing Organization) Services: Fee-for-service precision fermentation expertise offered as a CDMO to biomanufacturers. Services span clone development, strain engineering, bioprocess and analytical test development, fermentation scale-up, and large-scale commercial manufacturing.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Laurus Bio product offering

Product offering

Core offering

Laurus Bio manufactures animal-origin-free (AOF) recombinant proteins, growth factors, and cell culture media supplements using precision fermentation technology. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from clone development and process optimization through commercial-scale cGMP-compliant biomanufacturing.

Product overview

Laurus Bio is an integrated research-driven biomanufacturing organization offering a portfolio of 100% animal-origin-free (AOF) recombinant proteins and growth factors manufactured through precision fermentation technology. The core product portfolio consists of Rc Trypsin (standard and USP grade), Rc Human Albumin (10% and 20%), Rc Transferrin, Rc Carboxypeptidase B, Rc Thermolysin, Rc FGFb, Rc EGF-L, and Rc IGF1-LR3. These products serve diverse applications including cultured meat, cell culture media, biologics and insulin manufacturing, vaccines, and stem cell culture and regenerative medicine. The company also provides CDMO (Contract Development and Manufacturing Organization) services for precision fermentation, encompassing clone development, strain engineering, bioprocess development, and scale-up capabilities ranging from R&D bench-scale to commercial-scale production (up to 45,000L fermenters). Additionally, Laurus Bio offers customized cell culture media formulations and bio-analytics services. All products are manufactured using expression systems including Escherichia Coli, Pichia Pastoris, and Hansenula polymorpha.

Differentiator

Problem solved

Functional benefit

Products and services

  • Rc Carboxypeptidase B
  • Rc Human Albumin 20%
  • Rc USP Trypsin
  • Rc Trypsin (Standard)
  • Rc Transferrin
  • Rc Thermolysin
  • Rc Human Albumin 10%
  • Rc FGFb (basic Fibroblast Growth Factor)
  • Rc EGF-L (Epidermal Growth Factor - Long)
  • Rc IGF1-LR3
  • CDMO Services

Quantifiable outcome

  • 20 billion doses of medicines made safe with animal-free products
  • +2 more outcomes

Companies that use Laurus Bio

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Laurus Bio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Laurus Bio partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Laurus LabscoreOthersLaurus Bio is a wholly-owned subsidiary of Laurus Labs, a listed pharmaceutical company. Laurus Labs provides corporate governance, strategic direction, and operational support. Laurus Bio's corporate goals are aligned with those of Laurus Labs. The subsidiary model allows Laurus Bio to leverage Laurus Labs' pharmaceutical industry expertise and resources.
  • National Biomedical Resources Indigenization Consortium (NBRIC)minorStrategic or Co-development PartnerLaurus Bio (formerly Richcore Life Sciences) is a member of NBRIC, a consortium focused on indigenous development of biomedical resources in India. Through this membership, Laurus Bio participates in national initiatives to build self-sufficiency in biotech manufacturing, including the expansion of recombinant protein manufacturing capabilities.
  • Unreasonable GroupminorOthersLaurus Bio (formerly Richcore Life Sciences) was recognized as an Unreasonable Company by the Unreasonable Group, a community of entrepreneurs addressing global challenges. This recognition highlights the company's mission to create safer, more reliable, and more sustainable solutions to tackle current health problems through animal-origin-free biomanufacturing.

Scale indicators7 records

Recent moves8 records

Expansion highlights6 records

Laurus Bio competitors and assessment

Company assessment

Direct peers

  • Geltor: Animal-free recombinant protein company producing proteins via precision fermentation for food, beauty, and nutrition markets. Direct competitor in animal-origin-free recombinant protein space serving similar end markets.
  • Bota Bio: Precision fermentation CDMO offering end-to-end microbial manufacturing services from strain engineering to commercial production. Directly comparable to Laurus Bio's CDMO offering for novel proteins and bio-based products.
  • Culture Biosciences: Microbial fermentation CDMO with bioreactor scale-up capabilities and bioprocess development services. Operates a similar business model to Laurus Bio's CDMO services for synthetic biology and fermentation-based manufacturers.
  • Perfect Day: Animal-free dairy protein producer using precision fermentation, competing in the same AOF recombinant protein market as Laurus Bio. Both companies serve food industry customers seeking sustainable alternatives to animal-derived ingredients.

Broad incumbents

  • Bio-Techne: Major supplier of recombinant proteins and cell culture reagents (R&D Systems brand) for biopharma and academic customers. Direct competitor in recombinant growth factors and cell culture media supplements.
  • ADM: Global food ingredient and agricultural processor with growing fermentation and alternative protein capabilities. Competes in the alternative protein space with fermentation-based ingredients, similar to Laurus Bio's cultivated meat serving strategy.
  • Codexis: Engineered enzyme and protein manufacturer using directed evolution and protein engineering. Operates in pharmaceutical, food, and industrial markets with overlapping recombinant protein capabilities.
  • DSM-Firmenich: Major ingredient and biopharma supplier with fermentation-based manufacturing capabilities across nutrition, health, and personal care. Serves similar end markets to Laurus Bio but at much larger scale with diversified portfolio.
  • Novonesis: Large global enzyme and microbial fermentation company (formerly Novozymes) with extensive CDMO capabilities and precision fermentation infrastructure. Operates across food, beverage, and biopharma with broader portfolio than Laurus Bio.

Emerging players

  • Ginkgo Bioworks: Synthetic biology platform company providing cell engineering and fermentation services to customers across food, pharma, and industrial biotechnology. Comparable CDMO-like service offerings for novel protein customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Laurus Bio social profiles

Digital presence

Laurus Bio compliance and trust

Trust signal

Compliance5 records

Laurus Bio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Laurus Bio leadership team

Management profile

Number of profiles

Profiles9 records

Laurus Bio funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Laurus Bio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laurus Bio

What does Laurus Bio do?

Laurus Bio manufactures animal-origin-free (AOF) recombinant proteins, growth factors, and cell culture media supplements using precision fermentation technology. The company also operates as a Contract Development and Manufacturing Organization (CDMO), offering end-to-end services from clone development and process optimization through commercial-scale cGMP-compliant biomanufacturing.

Is Laurus Bio a public or private company?

Laurus Bio is a private company. It is classified as corporate owned and is currently operating.

When was Laurus Bio founded?

Laurus Bio was founded in 2005. It employs 501 to 1,000 people.

Where is Laurus Bio based?

Laurus Bio is headquartered in Bangalore, India, in the Asia region.

How does Laurus Bio make money?

Two revenue lines are on record. Recombinant Protein and Growth Factor Product Sales are the primary driver. The others are CDMO (Contract Development and Manufacturing Organization) Services.

Who are Laurus Bio's main competitors?

Direct peers on record are Geltor, Bota Bio, Culture Biosciences and Perfect Day. Broad incumbents are Bio-Techne, ADM, Codexis, DSM-Firmenich and Novonesis. Ginkgo Bioworks is listed as an emerging player.

Does Laurus Bio have an API?

No public API is recorded for Laurus Bio.

What industry is Laurus Bio in?

Laurus Bio's product category is Recombinant Proteins & Biomanufacturing. Its primary akta.pro industry code is AFANAKAF, Bioprocessing & Fermentation Manufacturing (Bioreactors, Scale-Up, Toll/CMO). Its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals